Protalix Biotherapeutics Inc. (PLX)
NYSE · Healthcare
Protalix Biotherapeutics Inc. Net Income 2009–2025
Protalix Biotherapeutics Inc. annual/quarterly net income history and growth rate from 2009 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Protalix Biotherapeutics Inc. net income for the quarter ending March 31, 2026 was 18.3 M, a 606.13% decrease year-over-year.
- Protalix Biotherapeutics Inc. net income for the twelve months ending March 31, 2026 was 17.2 M, a 418.01% decrease year-over-year.
- Protalix Biotherapeutics Inc. annual net income for 2025 was -6.6 M, a 325.24% decrease from 2024.
- Protalix Biotherapeutics Inc. annual net income for 2024 was 2.9 M, a 64.73% decrease from 2023.
- Protalix Biotherapeutics Inc. annual net income for 2023 was 8.3 M, a 155.68% decrease from 2022.
- Protalix Biotherapeutics Inc. annual net income for 2022 was -14.9 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Protalix Biotherapeutics Inc. Net Income — FAQ
Protalix Biotherapeutics Inc. (PLX) net income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Protalix Biotherapeutics Inc.'s net income?
Protalix Biotherapeutics Inc. (PLX) reported net income of -$7M for fiscal 2025.
Where can I see PLX's net income history?
The chart and table above show Protalix Biotherapeutics Inc.'s net income by year and by quarter, including the growth rate.